Medicaid is the largest funding source of health services for the poorest people in the United States. Medicaid enrollees have greater health care, needs, and higher health risks than other individuals in the country and, experience disproportionately low rates of preventive care. Without, Medicaid coverage, poor uninsured adults may not be vaccinated or would, rely on publicly-funded programs that provide vaccinations. We examined each programs' policies related to benefit coverage and, copayments for adult enrollees. Our study was completed between October 2011 and September 2012 using a document review and a survey of Medicaid administrators that assessed coverage and cost-sharing policy for fee-for-service programs. Results were compared to a similar review, conducted in 2003. Over the past 10 years, Medicaid programs have typically maintained or expanded vaccination coverage benefits for adults and nearly half have explicitly prohibited copayments. The 17 programs that cover all recommended vaccines while prohibiting, copayments demonstrate a commitment to providing increased access to vaccinations for adult enrollees. When developing responses to fiscal and political challenges, the programs that do not cover all ACIP recommended adult vaccines or those that permit copayments for vaccinations, should consider all strategies to increase vaccinations and reduce costs to enrollees.
While federal law outlines minimum requirements for all Medicaid programs, including mandatory benefits for a defined beneficiary population, each state retains authority to define several aspects of the program, including optional benefits, provider payment levels, and delivery systems. Vaccination services for adult enrollees are governed at the program level: each state determines which adult vaccines will be covered, enrollee cost-sharing policy, provider reimbursement policy, and the settings where vaccines may be administered.
Medicaid enrollees have greater health care needs and higher health risks than other individuals in the country [5, 6] . Nondisabled enrollees report their health status to be fair or poor (33%) at approximately triple the rate of privately insured individuals (12%) [7] and experience disproportionately low rates of preventive care [5, 8] . They may not be able to afford preventive services due to their relatively high cost in relation to enrollee incomes [9] . Under the Patient Protection and Affordable Care Act (PPACA), also known as health reform, vaccination coverage benefits remain an optional service for adult enrollees who were enrolled in Medicaid beneficiary categories established before January 1, 2014. However, beginning January 1, 2014, Medicaid programs covering all adult vaccines recommended by the Advisory Committee on Immunization Practices (ACIP) and their administration costs while prohibiting cost-sharing will receive an additional 1% Federal Medical Assistance Percentage (FMAP) [10] . The FMAP determines the amount of federal matching funds that states receive for Medicaid expenditures. Additionally, the PPACA requires programs to cover vaccines in accordance with ACIP recommendations for newly eligible adults who enroll on or after January 1, 2014.
However, because many states may not participate in program expansion under the PPACA, millions of adults who would otherwise be eligible to enroll in Medicaid will not have ensured access to vaccinations. Without Medicaid coverage, poor uninsured adults may not be vaccinated or would rely on publicly-funded programs that provide vaccinations [11] .
Our study assessed benefit coverage and cost-sharing for vaccination services for noninstitutionalized adults among fee-for-service programs throughout the country, excluding the 5 U.S. Territories. This review analyzes how states respond to changes in regulatory and fiscal environments and how these changes impact access to recommended vaccinations for millions of poor adults.
Methods
Between October 2011 and September 2012, we conducted a document review and developed and administered a survey assessing coverage and cost-sharing policy for Medicaid fee-for-service programs. The results were compared to our 2003 study entitled The Epidemiology of US Immunization Law: Medicaid Coverage of Immunizations for Non-Institutionalized Adults (2003 study) [12] .
Document review
The document review included materials from all 51 programs. From October 2011 through March 2012, we conducted a web-based document search, using search terms: "Medicaid fee schedule," "Medicaid physician visit cost-sharing", and "adult Medicaid immunization or vaccination." The search yielded state-issued provider manuals, physician bulletins and newsletters, consumer handbooks, fee schedules, commercially available state plan summaries, and Current Procedural Terminology (CPT) codes related to coverage of, costsharing and payment for adult vaccination services under Medicaid.
Survey population
Medicaid administrators from 50 states and DC were asked to complete a survey, and verify the results from the document review and the 2003 study. This study was exempted from review in accordance with guidelines of our Institutional Review Board (IRB).
Survey design and administration
We developed a survey in collaboration with the National Center for Immunization & Respiratory Diseases (NCIRD) Immunization Services Division (ISD) of the Centers for Disease Control and Prevention (CDC).
On March 14, 2012, we emailed a letter signed by a CDC official and the principal investigator to each Medicaid program director. The letter introduced the project, provided links and attachments to study materials, and provided instructions for submitting completed responses. The survey was disseminated using Survey Monkey, an online survey tool.
We queried administrators about the programs' fee-for-service plans' coverage of vaccines recommended for adults in 2012, whether the program prohibits cost-sharing for adult vaccination services, and about their reimbursement policy, anticipated response to health reform, and adult vaccination program management.
Rank order scale questions were used to prioritize the factors that influence coverage decisions [13] . Open-ended questions were used to determine how the 1% FMAP increase would affect program coverage or cost-sharing decisions for adult vaccinations and to identify the reimbursement rates for adult vaccines [13] . We used multiple choice questions to determine coverage levels for beneficiaries enrolled before January 1, 2014 and to determine the factors that influence coverage decisions [13] .
Between April 2, 2012 and September 5, 2012, participants who had not submitted completed surveys received follow-up e-mails and phone calls every two weeks or as necessary. Participants submitted completed surveys via e-mail, facsimile, or online between March 18, 2012 and September 28, 2012 . No state attempted to submit a survey after September 28, 2012.
Comparison of 2012 data to 2003 study
The results of the 2003 document review included data from 50 of the 51 programs. In 2003, data from DC was unavailable; but was obtained for the 2012 update. We compared the 2003 and 2012 research results to determine whether coverage, cost-sharing, or provider reimbursement policies changed. In the 2003 study, only 1 CPT code per vaccine was used as a measure of benefit coverage and may have resulted in an underestimation of coverage. The 2012 study incorporates all CPT codes applicable to each vaccine under review to ensure accurate measurement of vaccine benefit coverage.
Results

Survey response and characteristics of respondents
By October 1, 2012, 42/51 programs (82%) responded to the survey. Of the 9 programs that did not complete the survey, 2 programs (WV, WI) declined to participate and 7 (IL, KS, NH, NC, OH, PA, and RI) did not respond.
The 42 responding programs cover approximately 16 million of the more than 19 million Medicaid enrollees ages 19 through 64 [4] . Respondents included 6 of the 10 largest programs and covered 41% of all enrollees ages 19 through 64. The median respondent program has approximately 223, 210 enrollees in this age group. Table 1 Table 1) .
Vaccine benefit coverage
Most of the states that did not cover all ACIP recommended vaccines in 2003 increased benefit coverage to include hepatitis A and B, influenza, meningococcal, and Td vaccines by 2012. However, four states (GA, ND, SD, and TX) decreased coverage since 2003. Georgia eliminated the highest number of vaccines and no longer covers MMR, varicella, Td or pneumococcal vaccines, but added HPV and zoster. Even though LA and MS cover the fewest vaccines, both states now offer HPV, influenza, and pneumococcal vaccines (Table  1) .
In 2012, influenza vaccine was the most frequently covered vaccine (98%, 50/51), with 6 different formulations available for use among adults. While DE, MA, and NH are the only programs that covered all 6 influenza vaccines, 88% of programs (45/51) covered the 
Factors influencing benefit coverage decisions
Administrators were asked to rank the factors influencing their decisions to cover vaccines from most influential (1st) to least influential (5th). Most of the 42 programs responding to the survey ranked ACIP recommendations first or second (31/42). Programs also identified a recommendation to the program by a state health agency (22/42), interest from legislators and the governor (13/42), and public interest (3/42) as first or second most influential factors.
Other primary or secondary factors included approval of the Food and Drug Administration (FDA) (1/42), "good public policy," (1/42) and good return on investment (1/42). For example, Oregon indicated the most influential factor was an OR Health Evidence Review Commission (HERC) recommendation. The HERC prioritizes health services and evidencebased guidelines for providers, consumers, and purchasers of health care in Oregon [14] .
Programs cited costs associated with vaccine coverage (10/42) and lack of a state health agency recommendation (9/42) as the most influential factors when considering vaccines to exclude from coverage. Other factors ranked first or second include the desire for more long-term data (6/42), low demand or interest from state and local health professionals (5/42), and insufficient demand or interest from state legislators or governors (3/42). The lack of FDA approval (1/42) and concerns regarding medical necessity were infrequently cited (1/42).
Cost-sharing
Generally, Medicaid enrollees can be assessed multiple fees including sliding scale premiums or enrollment fees, copayments or deductibles paid to the provider, or coinsurance as a percentage of the total charges incurred for services [15] . Certain individuals are exempt from some cost-sharing: those receiving hospice care, American Indians and Alaska Natives receiving services from identified programs, and women enrolled in the Breast and Cervical Cancer Treatment Program [15, 16] . Some programs prohibit cost-sharing for various categories of services. Our study examines cost-sharing in the form of copayments.
In 2003, 23/50 programs permitted and 27/50 programs did not address copayments (data from DC unavailable), while no program prohibited copayments. By 2012, 2 additional programs permitted copayments (25/51), while 21/51 programs prohibited the practice. Five programs did not address cost-sharing for vaccinations.
Copayments from $0.50 to $3.00 were observed in 2003. By 2012, copayments ranged from $.50 to $3.40 or 5% of the allowable amount the program permits a provider to bill. (Mean of maximum copayments among states with reported copayment amounts = $2.81, median = $3.00, mode = $3.00). (Table 2 ).
In 2012, 7 programs (GA, LA, MN, NC, NE, NY, and PA) had conditional "no copayment" policies for vaccinations. These conditions depend upon the care setting, service provided, or the service provider. Four of these 7 programs (GA, MN, NE, and NY) prohibited copayments for physician, nurse practitioner, primary care, and physician extender, or private doctor office visits and services [17, 18] . Pennsylvania prohibited copayments for any vaccine administered by a physician, but Louisiana prohibited copayments only for influenza vaccine administered by pharmacists. North Carolina prohibited copayments for vaccination services unless the vaccine is provided as a prescription.
Effects of health reform on benefit coverage decisions
Medicaid program administrators were asked how their programs would respond to changes proposed under health reform. Most administrators indicated that their programs will not alter coverage policy for traditionally eligible enrollees (30/42). Of these 30 programs, 23 currently cover all recommended vaccines. Twelve of these 23 programs prohibit costsharing. Eleven of 42 programs were unclear about how they will respond; 5 of these 11 programs currently cover all recommended vaccines and 1 of those 5 also prohibits costsharing. Arkansas is the only program that reported an intention to increase vaccination coverage benefits for traditionally eligible adults to ensure the same benefit coverage as newly-eligible adults. No program reported the intent to decrease vaccination coverage benefits for traditionally eligible adults.
Discussion
Medicaid enrollees have few assets and generally cannot afford medical insurance in the private market [5, 19] . Medicaid policy related to vaccinations for adult enrollees directly impacts both the enrollee's personal health status and the public's health. Programs that cover all ACIP recommended vaccines and prohibit any form of cost-sharing support the Healthy People 2020 goals related to seasonal flu, pneumococcal, hepatitis B, and zoster vaccinations for adults [20, 21] .
Federal rules governing Medicaid do not require individual programs to include adult vaccines in their benefit packages. However, all programs, with the exception of Florida, incorporate some level of vaccination coverage benefit as part of comprehensive health care. Since 2003 when we last examined this topic, 4 states have expanded benefit coverage to incorporate all recommended vaccines. Consequently, 36 programs now cover vaccines in accordance with ACIP recommendations, including 8 of the 10 largest programs (i.e., all but FL and TX). Seventeen of these programs (17/36) also prohibit copayments. The adoption of all ACIP recommended vaccines while prohibiting copayments is an indication that adult vaccinations remain a priority for these programs.
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Most responding programs noted that they do not plan to alter their coverage and costsharing policies in order to receive the 1% FMAP increase offered under health reform. Because the imposition of even small copayments can impair access to care for poor individuals, programs that eliminate copayments could increase access to vaccinations for enrollees [22, 23] . Program administrators should evaluate all options to determine how eliminating cost-sharing and maximizing opportunities to receive additional federal funds will impact their program's ability to provide important preventive services to Medicaid beneficiaries.
We found that influenza vaccine is the most frequently covered vaccine (50/51), with 6 different formulations. The subunit preservative/antibiotic-free formulation (90661) Fifteen programs do not cover all ACIP recommended vaccines. Generally, the least frequently covered vaccines were HPV, varicella, and zoster. These vaccines are among the most recently recommended and most expensive vaccines. We noted that HPV and varicella vaccines are routinely indicated for use in children and may only be appropriate for adults as a catch-up service. Zoster vaccine is used in older adults, many of whom may be eligible to receive the vaccination under Medicare, the public insurance program serving adults ages 65 and older and qualified persons with disabilities. These age-related recommendations may partially explain the lack of vaccination coverage benefits among some programs.
We surmise that the size of the population at risk for vaccine-preventable diseases compared to the benefit programs expect to realize from vaccination, relative to the cost may determine vaccine coverage. Medicaid administrators may prefer to conserve resources and wait until their state public health department recommends a particular vaccine to the program. However, some programs may have decided to allocate their resources differently. The few states that decreased coverage since 2003, or covered the fewest vaccines have chosen to cover HPV and/or zoster, while excluding benefit coverage of older vaccines.
We think these examples illustrate the difficult and complicated process that program administrators must navigate when considering which vaccines to cover. Even though programs indicated that an ACIP recommendation was the most significant factor when determining whether to cover a vaccine, in the final analysis, cost has the greatest impact on vaccination benefit coverage decisions. These responses suggest that the effects of the nationwide economic recession, state budget and policy processes, fluctuations in revenue, long-term spending commitments, and each program's response to reduced funding for other vaccine programs, combine to compel fiscal limitations that result in benefit coverage decisions that impact access to vaccines [26] .
Our study has three main limitations. First, our survey excluded data from the 5 U.S. territories that participate in the Medicaid program, affecting our ability to identify the policies affecting enrollees in those areas. Second, our data collection excluded contracts from Medicaid managed care plans, limiting our efforts to examine policies that affect a significant portion of enrollees. An average of 66% of all Medicaid enrollees participate in some form of managed care. While this number includes many children and adults with children [27] , a significant number of adults receive Medicaid services through managed care plans. Future research related to vaccinations for adults enrolled in Medicaid could address these limitations by including Medicaid programs operating in the Territories and managed care plans. Finally, our 2003 study excluded review of certain CPT codes that were active for hepatitis A and B, and influenza vaccines. As a result, our findings for 2003 may underestimate insurance benefit coverage for those vaccines.
Over the past 10 years, Medicaid programs have typically maintained or expanded vaccination coverage benefits for adults, and nearly half have explicitly prohibited copayments.
The 17 programs that cover all recommended vaccines while prohibiting copayments demonstrate a commitment to providing increased access to vaccinations for adult enrollees. When developing responses to fiscal and political challenges, the programs that do not cover all ACIP recommended adult vaccines or those that permit copayments for vaccinations, should consider all strategies to increase vaccinations and reduce costs to enrollees.
Our findings suggest that Medicaid administrators are committed to developing policies that provide adult enrollees with evidence-based methods to protect themselves and the public's health and safety. When compared to other preventive services or medical benefits, vaccines are a cost-effective tool against infectious disease.
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Bold: covers all recommended vaccines in 2012. Data as of 2012. A-E Copayment for physician/outpatient hospital services: A = $1.00; B = $2.00; C = $3.00; D = $4.00; E = scaled cost-sharing ($.50 for services <$10, $1 for <$25, $2 for <$50, $3 for <$50+); F = 5% allowable amount; H = no copayment for office visits only; I = no copayment unless immunization is a prescription.
